BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co's AG013 for oral mucositis

* U.S. FDA grants fast track designation for the development of Oragenics' AG013 for oral mucositis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.